// company-profile

Artiva Biotherapeutics, Inc.

ARTV
ExchangeNasdaqSectorBiological Products, (No Diagnostic Substances)Inc.DEFilings61Insiders36
// api This Artiva Biotherapeutics, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.

// activity-summary

Recent insider activity is bullish. Over the last 30 days, 6 insiders purchased shares (net $12.3M). Buying was led by RA CAPITAL MANAGEMENT, L.P..

// 90-day insight

Over the last 90 days, Artiva Biotherapeutics, Inc. insiders bought $128.7M (12 transactions) and sold $478K (5 transactions).

  • Most active insider: RA CAPITAL MANAGEMENT, L.P. with 8 transactions totaling $112.2M.
  • Largest single purchase: $75.0M by RA CAPITAL MANAGEMENT, L.P. on May 11, 2026.

Activity skews bullish — buys outpace sales.

Institutional Ownership

Top 13F-HR holders of Artiva Biotherapeutics, Inc. as of 2026-03-31

↑ increasing
Total reported AUM
$108.2M
QoQ change
+50.6%
Reporting period
2026-03-31
#1
RA CAPITAL MANAGEMENT, L.P.
CIK 1346824
$63.5M
9.9M shares
#2
5AM Venture Management, LLC
CIK 1799883
$15.2M
2.4M shares
#3
Venrock Adviser, LLC
CIK 1615982
$10.4M
1.6M shares

Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Jun 16, 2026RA CAPITAL MANAGEMENT, L.P.ARTV
Purchase
124,893$8.89$1.11M
Jun 15, 2026RA CAPITAL MANAGEMENT, L.P.ARTV
Purchase
15,414$8.99$139K
Jun 12, 2026RA CAPITAL MANAGEMENT, L.P.ARTV
Purchase
391,019$8.57$3.35M
Jun 11, 2026RA CAPITAL MANAGEMENT, L.P.ARTV
Purchase
548,580$7.91$4.34M
Jun 10, 2026RA CAPITAL MANAGEMENT, L.P.ARTV
Purchase
103$7.00$1K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.